Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis

To estimate the impact of NICE approval of tumour necrosis factor inhibitor (TNFi) therapies on the incidence of total hip replacement (THR) and total knee replacement (TKR) among rheumatoid arthritis (RA) patients in England and Wales.

Source: Seminars in Arthritis and Rheumatism - September 23, 2017 Category: Rheumatology Authors: Samuel Hawley, Ren é Cordtz, Lene Dreyer, Christopher J. Edwards, Nigel K. Arden, Antonella Delmestri, Alan Silman, Cyrus Cooper, Andrew Judge, Daniel Prieto-Alhambra Source Type: research